Home/Filings/4/0001104659-20-069841
4//SEC Filing

Jantzen Beth 4

Accession 0001104659-20-069841

CIK 0000744452other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:32 PM ET

Size

5.5 KB

Accession

0001104659-20-069841

Insider Transaction Report

Form 4
Period: 2020-06-03
Jantzen Beth
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-03+6,9656,965 total
    Exercise: $8.36Exp: 2030-06-02Common Stock (6,965 underlying)
Footnotes (1)
  • [F1]The options vest immediately.

Issuer

APPLIED DNA SCIENCES INC

CIK 0000744452

Entity typeother

Related Parties

1
  • filerCIK 0001633940

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:32 PM ET
Size
5.5 KB